Top Markets
Coin of the day
Novartis India Limited Novartis India Limited

Novartis India Limited

NOVARTIND
Rang in aandelen #14311
Novartis India Limited, an Indian healthcare enterprise, provides a diverse... Novartis India Limited, an Indian healthcare enterprise, provides a diverse range of pharmaceutical solutions. Its offerings include branded medications for conditions related to bone and pain management, calcium supplementation, women's health (gynecology), and neurological disorders. Furthermore, the company supplies generic drugs specifically for gynecological issues, anti-tuberculosis treatments, and anti-infective applications. Notable branded products within its portfolio comprise Tegrital and Exelon for central nervous system disorders, Voveran for pain and inflammation relief, and specialized transplantation/immunology drugs like Simulect, Certican, Myfortic, and Sandimmun Neoral. Established in 1947 and headquartered in Mumbai, India, Novartis India Limited operates as a subsidiary of Novartis AG.
Aandeelprijs
$17.15
Laatst gesynchroniseerd: 2026-08-31
Marktkapitalisatie
$423.01M
Verandering (1 dag)
4.67%
Verandering (1 jaar)
112.68%
Land
IN
Handel Novartis India Limited (NOVARTIND)

Categorie

Dividendrendementgeschiedenis voor Novartis India Limited (NOVARTIND)
Het dividendrendement (TTM) van Novartis India Limited (aandelsymbool: NOVARTIND) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Novartis India Limited (NOVARTIND) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten